Angiostatin and angiostatin-related proteins

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 97-107

  Soff, G A ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Angiostatin; Apoptosis; Cancer biology; Cancer therapy; Proteolysis

Indexed keywords

ANGIOSTATIN;

ANGIOGENESIS; APOPTOSIS; CANCER THERAPY; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KRINGLE DOMAIN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; GENE THERAPY; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEIN CONFORMATION;

EID: 0034528886     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026525121027     Document Type: Review

References (38)

1. Tumor angiogenesis: Therapeutic implications
2. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
3. An elastase-dependent pathway of plasminogen activation
4. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin
5. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
6. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen
7. Angiostatin generation by human pancreatic cancer
8. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells
9. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin
10. 4.5: A naturally occurring human angiogenesis inhibitor
11. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
12. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
13. Matrix metalloproteinases generate angiostatin: Effects on neovascularization
14. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
15. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD
16. Multiple forms of angiostatin induce apoptosis in endothelial cells
17. Angiostatin binds ATP synthase on the surface of human endothelial cells
18. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells
19. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
20. The plasminogen-plasmin enzyme system
21. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
22. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells
23. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells
24. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth
25. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis
26. Elevated levels of urine angiostatin and plasminogen/plasmin in cancer patients
27. Diurnal variations in angiostatin in human tear fluid: A possible role in prevention of corneal neovascularization
28. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3
29. Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth
30. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
31. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases
32. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA
33. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B 16F10 melanoma cells
34. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
35. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents
36. Combined effects of angiostatin and ionizing radiation in antitumour therapy
37. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
38. Therapeutic application of an angiostatic cocktail for patients with refractory cancer